Clinical Trials Directory

Trials / Completed

CompletedNCT00534846

The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia

The Effect of Toremifene Treatment to the Magnetic Resonance Imaging Findings in Women Suffering From Premenstrual Mastalgia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Satakunta Central Hospital · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effect of toremifene treatment to the MRI findings of the breast in women suffering from premenstrual mastalgia.

Detailed description

Benign breast pain is a common complaint of women in western countries. As many as 41-69% of women reported having mastalgia sufficient to interfere with their daily routines. Approximately 8-10% of premenopausal women suffer monthly from moderate to severe breast pain.Tamoxifen has previously been found to be effective in reducing premenstrual mastalgia. We showed that another triphenylethylene derivative, toremifene, significantly alleviated cyclical breast pain as compared to placebo. In this study women suffering from cyclical breast pain are randomly allocated to receive toremifene (20mg) or placebo during the luteal phase for three consecutive cycles. The patients are then crossed over after a wash-out period to placebo or toremifene, respectively. The MRI investigations are made at two occasions during the premenstrual period after three cycles of toremifene and after three cycles of placebo.

Conditions

Interventions

TypeNameDescription
DRUGtoremifeneThe medication is given in tablet form, and the participants are instructed to take one tablet daily from cycle day 15 until the next menstruation. The active (toremifene 20 mg) and control (placebo) tablets were identical in appearance.
DRUGplacebotablet equal to toremifene, one tablet daily from cycle day 15 to menstruation during three cycles

Timeline

Start date
2007-04-01
Primary completion
2008-05-01
Completion
2009-02-01
First posted
2007-09-26
Last updated
2009-05-13

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00534846. Inclusion in this directory is not an endorsement.